Cure8 research brief
Pyoderma gangrenosum is an uncommon but important extraintestinal skin complication that can occur with ulcerative colitis and may be mistaken for infection. Recognizing it matters because treatment and wound care differ from antibacterial approaches.
Clinicians (dermatology, gastroenterology, primary care), adult patients with ulcerative colitis, caregivers.
This journal abstract reports a clinical case describing pyoderma gangrenosum (PG) as an extraintestinal skin manifestation in a patient with ulcerative colitis. The authors note skin rash on the lower limb, lack of response to antibiotics, and pathergy (worsening after minor trauma) as key features supporting the PG diagnosis.
The article’s main point is a reminder for clinicians across specialties to consider IBD-related skin complications when wounds or rashes do not respond to standard antibacterial care, since management differs from typical infections.
If you see a nonhealing, painful ulcer or worsening lesion after minor injury and you have IBD, clinicians may evaluate for PG and consult dermatology and gastroenterology; this abstract emphasizes awareness rather than new treatment data.
Single-case abstract only — useful as a clinical reminder but not evidence of how often PG occurs or which treatments work best. Diagnosis often needs dermatology and gastroenterology input.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
PSC is rare in the general population but substantially more common in people with IBD, particularly ulcerative colitis, and it raises long-term hepatobiliary risks including cholangiocarcinoma—so knowing how often PSC...
This meta-analysis suggests people with IBD—especially those with Crohn’s disease—have a modestly increased risk of stroke. That makes cardiovascular risk assessment and prevention potentially more important for people...
Extrapulmonary TB can be triggered or revealed during immunosuppressive biologic therapy and may mimic other causes of liver injury; early recognition and TB-specific testing are important for timely treatment and to...
